breast cancer
PURPOSE: We performed a phase I/II dose-escalation trial of cyclophosphamide,       mitoxantrone, and 5-fluorouracil (CNF) in combination with human recombinant       granulocyte-colony-stimulating factor (G-CSF, filgrastim) in patients with       advanced breast cancer.
PURPOSE: We performed a phase I/II dose-escalation trial of cyclophosphamide,       mitoxantrone, and 5-fluorouracil (CNF) in combination with human recombinant       granulocyte-colony-stimulating factor (G-CSF, filgrastim) in  @OBJECT$   @PREDICAT$        advanced  @SUBJECT$ .